Diabetes and outcomes in yellow fever: an overlooked determinant in a re-emerging threat

Alfonso J. Rodriguez-Morales; Kovy Arteaga-Livias

doi:10.54034/mic.e2688

Authors

Alfonso J. Rodriguez-Morales Fundación Universitaria Autónoma de las Américas-Institución Universitaria Visión de las Américas, Pereira, Colombia
Kovy Arteaga-Livias Universidad Nacional Hermilio Valdizan, Huanuco, Peru

DOI:

https://doi.org/10.54034/mic.e2688

References

1. Cuellar-Saenz JA, Rodriguez-Morales AJ, Faccini-Martinez AA. Reemergence of Yellow Fever, Magdalena Valley, Colombia, 2024-2025. Emerg Infect Dis. 2025;31(12):2216-24.

2. Reno E, Quan NG, Franco-Paredes C, Chastain DB, Chauhan L, Rodriguez-Morales AJ, et al. Prevention of yellow fever in travellers: an update. Lancet Infect Dis. 2020;20(6):e129-e37.

3. Angerami RN, Socorro Souza Chaves TD, Rodriguez-Morales AJ. Yellow fever outbreaks in South America: Current epidemiology, legacies of the recent past and perspectives for the near future. New Microbes New Infect. 2025;65:101580.

4. Rodriguez-Morales AJ, Torres-Hernandez D, Guevara ME, Chang-Cojulun A, Brea-Del Castillo J, Rios-Blanco R, et al. Yellow fever in children and adolescents amid the South American outbreak, 2024/2025. New Microbes New Infect. 2025;67:101635.

5. Ho YL, Joelsons D, Leite GFC, Malbouisson LMS, Song ATW, Perondi B, et al. Severe yellow fever in Brazil: clinical characteristics and management. J Travel Med. 2019;26(5).

6. Rodriguez-Morales AJ, Chang-Cheng B, Gross R, Llanque-Espinoza OE, Villamil-Macareno J, Pacheco-Jimenez C, et al. Clinical features of yellow fever in cases from Bolivia, Ecuador, Colombia, and Peru (2023-2025): A descriptive retrospective study. New Microbes New Infect. 2025;68:101651.

7. Rodriguez-Morales AJ, Sah R, Silva-Ramos CR, Pava-Garzon DM. Challenges in Emerging and Reemerging Arboviral Diseases: The Examples of Oropouche and Yellow Fever. Pathogens. 2025;14(7).

8. Badawi A, Velummailum R, Ryoo SG, Senthinathan A, Yaghoubi S, Vasileva D, et al. Prevalence of chronic comorbidities in dengue fever and West Nile virus: A systematic review and meta-analysis. PLoS One. 2018;13(7):e0200200.

9. McClure M, de Rezende IM, Pereira LS, Dutra MRT, Fradico JRB, Macedo R, et al. Risk factors associated with in-hospital mortality during the yellow fever outbreak in Brazil. Front Med (Lausanne). 2025;12:1505005.

10. Avelino-Silva VI, Thomazella MV, Marmorato MP, Correia CA, Dias JZC, Maestri A, et al. Viral Kinetics in Sylvatic Yellow Fever Cases. J Infect Dis. 2023;227(9):1097-103.

11. Hamer DH, Angelo K, Caumes E, van Genderen PJJ, Florescu SA, Popescu CP, et al. Fatal Yellow Fever in Travelers to Brazil, 2018. MMWR Morb Mortal Wkly Rep. 2018;67(11):340-1.

12. Forero-Delgadillo AJ, Morales-Olivera JA, Celis-Guzman JF, Zapata-Diaz OE, Gonzalez-Varona GA, Acevedo-Bedoya CA, et al. Colombian consensus on the care of critically ill patients with suspected or confirmed severe yellow fever. Lancet Reg Health Am. 2025;48:101144.

13. Escalera-Antezana JP, Lizon-Ferrufino NF, Maldonado-Alanoca A, Alarcon-De-la-Vega G, Alvarado-Arnez LE, Balderrama-Saavedra MA, et al. Risk factors for mortality in patients with Coronavirus Disease 2019 (COVID-19) in Bolivia: An analysis of the first 107 confirmed cases. Infez Med. 2020;28(2):238-42.

14. Volpe M, Battistoni A, Gabutti G, Bonanni P, Nati G, Siliquini R. Cardiovascular disease related to influenza infection and the protective role of influenza vaccination. Int J Cardiol. 2026;448:134178.

15. Distenhreft JIQ, Couto-Lima D, Andreazzi CS, Thomazini J, Vasconcellos Filho LM, Falqueto A, et al. Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease. J Bras Nefrol. 2024;46(4):e20230202.

16. Dubankova A, Boura E. Structure of the yellow fever NS5 protein reveals conserved drug targets shared among flaviviruses. Antiviral Res. 2019;169:104536.

17. de Oliveira Figueiredo P, Stoffella-Dutra AG, Barbosa Costa G, Silva de Oliveira J, Dourado Amaral C, Duarte Santos J, et al. Re-Emergence of Yellow Fever in Brazil during 2016-2019: Challenges, Lessons Learned, and Perspectives. Viruses. 2020;12(11).